Photodiagnosis and Photodynamic Therapy for CNS Tumors
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 28 February 2027 | Viewed by 118
Editor
Interests: photodynamic therapy; photosensitizer; cancer therapy; laser; reactive oxygen species; apoptosis; optical fiber
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In 1998, a journal cover featured a red-glowing intraoperative photograph of malignant glioma. Many brain tumor surgeons, including myself, who had personally experienced the difficulty of operating on malignant brain tumors, were strongly impressed. Upon learning that fluorescent dyes known as photosensitizers could serve as powerful guides for brain tumor surgery and could further develop into treatments utilizing their tumor cell-selective accumulation, brain tumor surgeons worldwide simultaneously began research into photodynamic medicine. Twenty years have passed since the establishment of fluorescence-guided resection (FGR) using 5-ALA. Researchers worldwide have accumulated findings on the efficacy of FGR using 5-ALA, and it is now becoming a standard procedure in CNS tumor surgery. Furthermore, findings on the efficacy and safety of photodynamic therapy, which utilizes the tumor cell-selective accumulation of photosensitizers, are being updated annually, primarily in Japan, the EU, and the US.
This Special Issue compiles the latest information on photo-diagnosis and photodynamic therapy for central nervous system (CNS) tumors, aiming to explore future prospects for further clinical contributions.
Prof. Dr. Jiro Akimoto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photo-diagnosis
- photodynamic therapy
- central nervous system tumors
- photosensitizer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
